AI assistant
Sending…
BioAtla, Inc. — Director's Dealing 2021
Jun 17, 2021
34681_dirs_2021-06-16_62b8f855-d0da-4cd0-88fe-a78354338384.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioAtla, Inc. (BCAB)
CIK: 0001826892
Period of Report: 2021-06-14
Reporting Person: Sievers Eric (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-14 | Common Stock | J | 23726 | $0.00 | Acquired | 100649 | Direct |
Footnotes
F1: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration.
More from BioAtla, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 11
Regulatory Filings
2026
Feb 9
Regulatory Filings
2026
Feb 6